CUSIP: 61023L207 | NYSE | Healthcare · Biotechnology | Small Cap | 139 institutional holders
5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.
| Holder | Shares | % of Class | Change | Event Date | vs 13F |
|---|---|---|---|---|---|
| 13GBlackRock, Inc. | 338,133 | 5.0% | New 5%+ stake | Sep 30, 2026 | 92d ahead of 13F (348,819 sh) · −10,686 |
| 13G/AAdage Capital Management, L.P. | 324,195 | 4.8% |
| Style | Turnover | Location | Filed | ||||
|---|---|---|---|---|---|---|---|
| 129,797 | $10.4M | 0.0% | Growth | Medium | Strassen, Netherlands | 2026-11-03 | |
| 7,977 | $635.5K | 0.0% | Index | Very Low | Overland Park, KS | 2026-11-02 | |
| 5,601 | $446.2K | 0.2% | ETF | Low | Columbus, OH | 2026-10-21 | |
| 2,462 | $196.1K | 0.0% | Core | Medium | New York, NY | 2026-11-04 | |
| 104 | $8.3K | 0.0% | GARP | Medium | Charlotte, NC | 2026-10-22 | |
| 39 | $3.1K | 0.0% | Index | Very Low | Foster City, CA | 2026-10-08 | |
| 24 | $1.9K | 0.0% | Index | Low | San Francisco, CA | 2026-10-08 | |
| 13 | $1.0K | 0.0% | Core | Very Low | Saint Louis, MO | 2026-10-27 | |
| 6 | $479 | 0.0% | ETF | Very Low | Sylvania, OH | 2026-10-26 | |
| 5 | $398 | 0.0% | ETF | Medium | Scottsdale, AZ | 2026-10-14 | |
| 3 | $239 | 0.0% | Core | Low | Springfield, MA | 2026-10-05 | |
| 2 | $159 | 0.0% | ETF | Low | Fort Lauderdale, FL | 2026-10-30 | |
| 2 | $159 | 0.0% | Growth | Very High | Hong Kong, South Korea | 2026-10-29 | |
| 1 | $80 | 0.0% | Core | Medium | Birmingham, AL | 2026-11-04 |
| Newly reported |
| Jun 30, 2026 |
| No 13F filer matched |
| 13G/ASaturn V Capital Management LP | 313,384 | 4.7% | Newly reported | Jun 30, 2026 | No 13F filer matched |
| 13D/ARobinson Chandler with Brown Michael J, Tactic Pharma LLC | 307,370 | 4.5% | −198,829 | Jan 28, 2026 | No 13F filer matched |
| 13D/AO'Halloran Thomas V. | 272,026 | 4.1% | Newly reported | Sep 24, 2025 | No 13F filer matched |